Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

A Minimum Fluid Volume Of 75 ML Is Needed To Ensure Adequacy In A Pleural Effusion: A Retrospective Analysis Of 2540 Cases

Lisa M. Rooper, S. Ali, M. Olson
Published 2014 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
No consensus exists regarding minimum fluid volume for adequacy of benign pleural effusion specimens. Although any volume is acceptable if cytologic findings are malignant, the distinction between the absence of disease and false‐negativity is not straightforward in low‐volume specimens. Recent literature has offered conflicting results regarding what minimum volume is necessary. Moreover, no studies to date have evaluated this issue across a large series of specimens with a wide distribution of volumes. The objective of the current study was to determine the minimum volume of pleural fluid necessary for optimal cytopathological diagnosis.
This paper references
10.1111/j.1365-2303.2010.00786.x
An investigation of adequate volume for the diagnosis of malignancy in pleural fluids
S. Thomas (2011)
10.1378/chest.08-2002
A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion.
W. Abouzgheib (2009)
10.1093/AJCP/72.1.48
Comparison of the diagnostic values of biopsies of the pleura and cytologic evaluation of pleural fluids.
B. Frist (1979)
10.4132/KoreanJPathol.2013.47.5.405
Cytotechnologists and On-Site Evaluation of Adequacy
J. Collins (2013)
The pleure;state of the art
S. A. Sahn (1988)
10.1164/AJRCCM/138.1.184
State of the art. The pleura.
S. Sahn (1988)
10.1016/S0025-6196(12)60212-2
Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.
U. Prakash (1985)
10.1111/J.2397-2335.1935.TB04208.X
The Logic of Inductive Inference
R. A. Fisher (1935)
10.1378/CHEST.122.6.1913
Volume of pleural fluid required for diagnosis of pleural malignancy.
Susan M. Sallach (2002)
10.1378/CHEST.67.5.536
Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura.
W. Salyer (1975)
10.1136/thx.45.2.81
Management of malignant pleural effusions.
M. Tattersall (1990)
10.1378/CHEST.91.6.817
Thoracocentesis. Clinical value, complications, technical problems, and patient experience.
T. Collins (1987)
10.1201/B14205-28
Malignant pleural effusions.
S. Sahn (1985)
10.1214/AOS/1016218224
SCALE SPACE VIEW OF CURVE ESTIMATION
P. Chaudhuri (2000)
10.1159/000345696
Malignant Pleural Effusion Resulting from Metastasis of Thyroid Primaries: A Cytomorphological Analysis
M. Olson (2013)
10.1001/ARCHINTE.1973.03650120060011
Cells in pleural fluid. Their value in differential diagnosis.
R. Light (1973)
10.1378/CHEST.107.3.845
The impact of thoracoscopy on the management of pleural disease.
R. J. Harris (1995)
THE COMPARATIVE DIAGNOSTIC ACCURACY, EFFICIENCY AND SPECIFICITY OF CYTOLOGIC TECHNICS USED IN THE DIAGNOSIS OF MALIGNANT NEOPLASM IN SEROUS EFFUSIONS OF THE PLEURAL AND PERICARDIAL CAVITIES.
H. Grunze (1964)
10.1378/chest.09-0641
Prospective study to determine the volume of pleural fluid required to diagnose malignancy.
J. Swiderek (2010)
10.1183/09031936.97.10081907
Pleural diseases related to metastatic malignancies.
S. Sahn (1997)



This paper is referenced by
10.1093/ajcp/aqaa058
Suspicious for Malignancy Diagnoses on Pleural Effusion Cytology.
E. Rodriguez (2020)
10.1002/cncy.22021
Ancillary studies in pleural, pericardial, and peritoneal effusion cytology
K. Sundling (2018)
10.1016/J.LUNGCAN.2019.05.017
Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting 'Direct to LAT' in selected groups.
S. Tsim (2019)
10.1080/15513815.2018.1494231
Comparative Analysis of Flow Cytometry and Cytomorphology for Neuroblastoma Cell Detection in Effusion and Bone Marrow Specimens
Wensong Ye (2019)
10.1093/ajcp/aqv021
A Minimum Volume of More Than 60 mL Is Necessary for Adequate Cytologic Diagnosis of Malignant Pericardial Effusions.
Lisa M. Rooper (2016)
10.3892/ol.2019.10118
Label-free microfluidic chip for the identification of mesothelial cell clusters in pleural effusion
L. Zhao (2019)
10.1016/j.jasc.2020.04.001
Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies Guideline from the College of American Pathologists (CAP): implications for the cytology community.
P. VanderLaan (2020)
10.1002/dc.24653
Root cause analysis of indeterminate diagnoses in serous fluids cytopathology.
Hamza N. Gokozan (2020)
10.1016/j.jasc.2020.05.015
The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management.
D. Pinto (2020)
10.1016/J.JASC.2016.04.004
A specimen volume of ≥80 mL improves cytologic sensitivity for malignant ascites: a retrospective analysis of 2665 cases.
Lisa M. Rooper (2016)
10.1007/978-3-030-53908-5_2
Non-diagnostic (ND) and Adequacy
M. Saieg (2020)
10.1016/J.RMCLC.2015.06.008
ENFOQUE DIAGNÓSTICO EN EL PACIENTE CON DERRAME PLEURAL
W. M. Oyonarte (2015)
10.1016/j.ccm.2017.11.004
Malignant Pleural Effusion: From Diagnostics to Therapeutics.
R. Asciak (2018)
10.1159/000477148
Molecular Alterations in Patients with Pulmonary Adenocarcinoma Presenting with Malignant Pleural Effusion at the First Diagnosis
E. Rodriguez (2017)
10.1007/978-3-030-24059-2_9
Body Cavity Effusions and Washings
X. Jing (2020)
10.1007/978-3-030-53908-5
The International System for Serous Fluid Cytopathology
A. Chandra (2020)
10.1513/AnnalsATS.201902-189CME
Contemporary Approach to the Diagnosis of Malignant Pleural Effusion.
V. Kaul (2019)
10.1515/pp-2016-0001
Pre-analytical issues in effusion cytology
C. Michael (2016)
10.1183/2312508x.10023619
Optimal diagnosis and treatment of malignant pleual disease: challenging the guidelines
D. Arnold (2020)
10.1002/cncy.22255
Serous cavity fluids: Momentum, molecules, markers… and more!
Momin T Siddiqui (2020)
10.1016/j.jasc.2019.08.006
Proceedings of the American Society of Cytopathology Companion Session at the 2019 United States and Canadian Academy of Pathology Meeting Part 1: towards an International System for Reporting Serous Fluid Cytopathology.
B. Crothers (2019)
10.1055/s-0039-1695702
Molecular Testing on Pleural Fluid Samples.
S. Oh (2019)
10.1183/13993003.00349-2018
ERS/EACTS statement on the management of malignant pleural effusions
A. Bibby (2018)
10.5858/arpa.2020-0119-CP
Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies: Guideline From the College of American Pathologists in Collaboration With the American College of Chest Physicians, Association for Molecular Pathology, American Society of Cytopathology, American Thoracic
S. Roy-Chowdhuri (2020)
10.3390/diagnostics10121046
Diagnostics in Pleural Disease
Anand Sundaralingam (2020)
10.1111/cyt.12654
Management of cytological material, pre‐analytical procedures and bio‐banking in effusion cytopathology
M. Engels (2019)
10.1111/crj.12941
Recent developments in the management of pleural infection: A comprehensive review
E. Bedawi (2018)
10.1111/INSR.12155
Statistical Scale Space Methods
L. Holmström (2017)
10.1159/000493336
The Differential Diagnosis in Nonlymphoproliferative Malignant Pleural Effusion Cytopathology and Its Correlation with Patients’ Demographics
E. Rodriguez (2018)
10.1002/cncy.21634
Adequacy in voided urine cytology specimens: The role of volume and a repeat void upon predictive values for high‐grade urothelial carcinoma
C. VandenBussche (2016)
10.1111/cyt.12755
A 2‐year retrospective study on pleural effusions: A cancer centre experience
E. Valerio (2019)
10.1093/ejcts/ezy258
ERS/EACTS statement on the management of malignant pleural effusions
A. Bibby (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar